AI-Assisted IND Document Development: A New Model for Document Production

When people think about AI and IND documentation, the most intuitive idea is often:

“AI can help write the documents.”

But if text that was previously drafted by a medical writer is simply generated by AI instead, the underlying workflow has not fundamentally changed.

The greater impact of AI on IND document development may not be about who writes the words, but about changing how documents are produced.

IND Documents Rarely Start from a Blank Page

Protocols, Investigator’s Brochures (IBs), Informed Consent Forms (ICFs), and Pre-IND / IND-related written materials are not simply writing tasks.

Before formal drafting begins, development teams typically need to work through a substantial volume of source materials:

Study reports, nonclinical data, clinical pharmacology information, existing document versions, cross-functional inputs, management decisions, and revisions generated at different points in the development process.

The most time-consuming questions are often not about how to phrase a particular paragraph. They are questions such as:

Which version is current?

Where did this number come from?

Are the descriptions in the Protocol and IB consistent?

Has this decision been finalized?

Which SME needs to confirm this content?

If these questions have not been addressed upstream, even the fastest writer is still working from immature inputs.

AI First Changes the Production Layer

AI is particularly well suited to supporting the repetitive and information-intensive production work involved in document development.

This may include organizing source materials, extracting information, performing initial comparisons, building document structures, generating first drafts, comparing versions, and checking consistency across documents.

These activities have traditionally required substantial manual effort. When AI can assist with part of this work, the distance between source materials and a first draft can be shortened.

But that does not mean professional review can be removed from the downstream workflow.

Quite the opposite.

The faster documents can be produced, the more important review and decision control become.

A Polished Draft Is Not the Same as a Usable Document

Generative AI can readily produce text that is well structured and professionally written.

That is both its value and its risk.

When a document looks sufficiently complete, it becomes easy to mistake “written like a formal document” for “the content has been confirmed.”

In clinical development, these are very different things.

A document that is actually ready to move forward still needs to answer questions such as:

Are the sources traceable?

Is the content consistent with related documents?

Have scientific conclusions been confirmed by the appropriate SMEs?

Are any key decisions still open?

Has the Sponsor accepted the relevant risks and assumptions?

For this reason, the most appropriate role for AI output is as production input, not as final authority.

The New Model Does Not Remove People—It Reallocates Their Time

In traditional document-development workflows, substantial senior capacity may be consumed by information retrieval, version comparison, formatting, and repeated revision of early drafts.

These activities matter, but they do not necessarily require the most senior professionals to perform every step from the beginning.

An AI-assisted workflow creates another possibility:

Use AI to compress repetitive production work, while preserving human capacity for source verification, cross-functional integration, professional judgment, and quality control.

This is why “AI-assisted medical writing” should not be reduced to the idea of replacing medical writers with AI.

The more meaningful change is a redistribution of work.

From Individual Documents to Integrated Package Thinking

Another easily overlooked issue is that IND documents do not exist as independent files.

The study population, dose, safety monitoring, and study procedures described in a Protocol may also affect the IB, ICF, and other related materials.

When each document is treated as an isolated writing task, cross-document inconsistencies can emerge.

AI can assist with comparing information across these documents. But someone still needs to assess the development package as a whole and determine whether a difference represents an appropriate document-specific distinction, a version-control problem, or a genuine inconsistency that requires resolution.

The emerging document-production model can therefore be summarized as:

AI-Assisted Production → Clinical Development Integration → Human Review & QC

What is being compressed is the document-production process—not professional review.

The value of AI is not simply that documents can be written faster. It is that qualified professionals can spend more of their time on the work that actually requires judgment.